American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 2,125 | 2,302 | 2,283 | 2,462 | 2,296 |
| Cost of Goods | 1,339 | 1,853 | 1,392 | 1,420 | 1,334 |
| Gross Profit | 786 | 449 | 891 | 1,042 | 962 |
| Operating Expenses | 1,487 | 1,803 | 1,512 | 1,492 | 1,465 |
| Operating Income | -362 | -501 | -229 | -30 | -169 |
| Interest Expense | 63 | 111 | 38 | 45 | 0 |
| Other Income | 2 | 48 | 3 | 1 | -42 |
| Pre-tax Income | -423 | -564 | -264 | -74 | -211 |
| Income Tax | -1 | 6 | 0 | -3 | -5 |
| Net Income Continuous | -422 | -570 | -264 | -71 | -206 |
| Net Income | $-422 | $-570 | $-264 | $-71 | $-206 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.01 | 0.00 | -0.01 |
| EBITDA(a) | $-286 | $-456 | $-188 | $12 | $-127 |